Open AccessGalactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study
Author(s) -
Ban Hock Tan,
Jenny G. Low,
Nidhi Loomba Chlebicka,
Asok Kurup,
Foong Koon Cheah,
Raymond Tzer Pin Lin,
Yeow Tee Goh,
Gee Chuan Wong
Publication year - 2011
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2011.01.011
Subject(s) - febrile neutropenia , medicine , voriconazole , aspergillosis , neutropenia , galactomannan , caspofungin , randomized controlled trial , surgery , chemotherapy , antifungal , immunology , dermatology
Patients with neutropenic fever after 4-7 days of broad-spectrum antibiotics are given antifungals empirically. This strategy may lead to over-treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom